
Girumsew Wendmagegn
Examiner (ID: 176, Phone: (571)270-1118 , Office: P/2484 )
| Most Active Art Unit | 2484 |
| Art Unit(s) | 2621, 2484 |
| Total Applications | 1118 |
| Issued Applications | 807 |
| Pending Applications | 62 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13729471
[patent_doc_number] => 20180369203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => METHODS OF TREATING CANCER BY ADMINISTERING A MEK INHIBITOR IN COMBINATION WITH A PROTEASOME INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/742725
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742725
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742725 | METHODS OF TREATING CANCER BY ADMINISTERING A MEK INHIBITOR IN COMBINATION WITH A PROTEASOME INHIBITOR | Aug 10, 2015 | Abandoned |
Array
(
[id] => 10672262
[patent_doc_number] => 20160018407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'METABOLIC PROFILES'
[patent_app_type] => utility
[patent_app_number] => 14/807920
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 18918
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14807920
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/807920 | METABOLIC PROFILES | Jul 23, 2015 | Abandoned |
Array
(
[id] => 10435029
[patent_doc_number] => 20150320041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'NON-AEROSOL FOAMING ALCOHOL HAND SANITIZER'
[patent_app_type] => utility
[patent_app_number] => 14/804632
[patent_app_country] => US
[patent_app_date] => 2015-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6030
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14804632
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/804632 | NON-AEROSOL FOAMING ALCOHOL HAND SANITIZER | Jul 20, 2015 | Abandoned |
Array
(
[id] => 10387949
[patent_doc_number] => 20150272957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'TOPICAL COMPOSITIONS AND METHODS OF TREATMENT OF ANORECTAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/740821
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20231
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14740821
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/740821 | Topical compositions and methods of treatment of anorectal disorders | Jun 15, 2015 | Issued |
Array
(
[id] => 10457902
[patent_doc_number] => 20150342917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'Autoimmune Disorder Treatment Using RXR Agonists'
[patent_app_type] => utility
[patent_app_number] => 14/732328
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 31413
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732328
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/732328 | Autoimmune Disorder Treatment Using RXR Agonists | Jun 4, 2015 | Pending |
Array
(
[id] => 11541615
[patent_doc_number] => 20170095440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'METHOD OF TREATING CANINE PANCREATITIS'
[patent_app_type] => utility
[patent_app_number] => 15/314697
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13845
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314697
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314697 | METHOD OF TREATING CANINE PANCREATITIS | May 28, 2015 | Abandoned |
Array
(
[id] => 10361006
[patent_doc_number] => 20150246012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'OMEGA 3 FATTY ACID FOR USE AS A PRESCRIPTION MEDICAL FOOD AND OMEGA 3 FATTY ACID DIAGNOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF CARDIOVASCULAR PATIENTS WITH CARDIOVASCULAR DISEASE (CVD) WHO ARE DEFICIENT IN BLOOD EPA AND DHA LEVELS'
[patent_app_type] => utility
[patent_app_number] => 14/708294
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12987
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14708294
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/708294 | OMEGA 3 FATTY ACID FOR USE AS A PRESCRIPTION MEDICAL FOOD AND OMEGA 3 FATTY ACID DIAGNOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF CARDIOVASCULAR PATIENTS WITH CARDIOVASCULAR DISEASE (CVD) WHO ARE DEFICIENT IN BLOOD EPA AND DHA LEVELS | May 10, 2015 | Abandoned |
Array
(
[id] => 11455878
[patent_doc_number] => 20170049785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'ESTROGEN COMBINATION FOR TREATMENT OF MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/307180
[patent_app_country] => US
[patent_app_date] => 2015-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12942
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307180
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/307180 | Estrogen combination for treatment of multiple sclerosis | Apr 26, 2015 | Issued |
Array
(
[id] => 11455813
[patent_doc_number] => 20170049718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'DRUG FOR TREATMENT OF TINNITUS PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 15/306389
[patent_app_country] => US
[patent_app_date] => 2015-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4831
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15306389
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/306389 | DRUG FOR TREATMENT OF TINNITUS PATIENTS | Apr 26, 2015 | Abandoned |
Array
(
[id] => 10421061
[patent_doc_number] => 20150306071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'Carbapenem Antibacterials with Gram-Negative Activity'
[patent_app_type] => utility
[patent_app_number] => 14/692973
[patent_app_country] => US
[patent_app_date] => 2015-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48562
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14692973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/692973 | Carbapenem antibacterials with gram-negative activity | Apr 21, 2015 | Issued |
Array
(
[id] => 12259329
[patent_doc_number] => 20180078525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'COMPOSITION FOR GROWTH PROMOTION, CONTAINING COUMARIC ACID AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 15/539487
[patent_app_country] => US
[patent_app_date] => 2015-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4331
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539487
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539487 | COMPOSITION FOR GROWTH PROMOTION, CONTAINING COUMARIC ACID AS ACTIVE INGREDIENT | Apr 13, 2015 | Abandoned |
Array
(
[id] => 10317180
[patent_doc_number] => 20150202182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'METHOD FOR ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 14/673153
[patent_app_country] => US
[patent_app_date] => 2015-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5757
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14673153
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/673153 | METHOD FOR ADMINISTRATION | Mar 29, 2015 | Abandoned |
Array
(
[id] => 10481822
[patent_doc_number] => 20150366840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'SALVINORIN COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/665755
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 20651
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665755
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/665755 | Salvinorin compositions and uses thereof | Mar 22, 2015 | Issued |
Array
(
[id] => 11393898
[patent_doc_number] => 20170014432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR REDUCING CHRONIC LOW-LEVEL INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 15/124057
[patent_app_country] => US
[patent_app_date] => 2015-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8080
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124057
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/124057 | COMPOSITIONS AND METHODS FOR REDUCING CHRONIC LOW-LEVEL INFLAMMATION | Mar 5, 2015 | Abandoned |
Array
(
[id] => 10289143
[patent_doc_number] => 20150174141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'METHOD FOR POST COITAL CONTRACEPTION IN OVERWEIGHT OR OBESE FEMALE SUBJECTS USING ULIPRISTAL ACETATE'
[patent_app_type] => utility
[patent_app_number] => 14/637567
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4537
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14637567
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/637567 | METHOD FOR POST COITAL CONTRACEPTION IN OVERWEIGHT OR OBESE FEMALE SUBJECTS USING ULIPRISTAL ACETATE | Mar 3, 2015 | Abandoned |
Array
(
[id] => 10559580
[patent_doc_number] => 09283233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-15
[patent_title] => 'Method for on-demand contraception'
[patent_app_type] => utility
[patent_app_number] => 14/635107
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2987
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635107
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/635107 | Method for on-demand contraception | Mar 1, 2015 | Issued |
Array
(
[id] => 10311516
[patent_doc_number] => 20150196517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'Autoimmune Disorder Treatment Using RXR Agonists'
[patent_app_type] => utility
[patent_app_number] => 14/626339
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 31465
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14626339
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/626339 | Autoimmune disorder treatment using RXR agonists | Feb 18, 2015 | Issued |
Array
(
[id] => 11455821
[patent_doc_number] => 20170049727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV Infection'
[patent_app_type] => utility
[patent_app_number] => 15/118752
[patent_app_country] => US
[patent_app_date] => 2015-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5714
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15118752
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/118752 | Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV Infection | Feb 11, 2015 | Abandoned |
Array
(
[id] => 10281943
[patent_doc_number] => 20150166940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'UNIVERSAL SURFACE DECONTAMINATION FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 14/616586
[patent_app_country] => US
[patent_app_date] => 2015-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8198
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14616586
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/616586 | UNIVERSAL SURFACE DECONTAMINATION FORMULATION | Feb 5, 2015 | |
Array
(
[id] => 10325708
[patent_doc_number] => 20150210712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'Prodrugs of Secondary Amine Compounds'
[patent_app_type] => utility
[patent_app_number] => 14/612853
[patent_app_country] => US
[patent_app_date] => 2015-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14998
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14612853
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/612853 | Prodrugs of secondary amine compounds | Feb 2, 2015 | Issued |